Bupropion Hydrochloride

Product NDC
50090-6961
11-digit product format
500906961
Labeler code
50090
Product ID
50090-6961_5e0daeb6-70e9-4d73-a260-7941e71b67f9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bupropion hydrochloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA210015
Marketing category
ANDA
Marketing start
2023-04-30
Substance
BUPROPION HYDROCHLORIDE
Active strength
300 mg/1
Pharmacologic classes
Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
ZG7E5POY8OBUPROPION HYDROCHLORIDE31677-93-7BUPROPION HYDROCHLORIDE

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
50090-6961-05009069610030 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6961-0) 2023-12-19NoNoHistorical
50090-6961-15009069610190 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6961-1) 2023-12-19NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Bupropion Hydrochloride XLA-S Medication Solutions2024-07-05HUMAN PRESCRIPTION DRUG LABEL5